5 results
424B5
TSHA
Taysha Gene Therapies Inc
27 Oct 22
Prospectus supplement for primary offering
5:13pm
or proxy contest, the assumption of control by a holder of a large block of our securities or the removal of incumbent management. Upon the affirmative vote
424B5
TSHA
Taysha Gene Therapies Inc
25 Oct 22
Prospectus supplement for primary offering
4:35pm
, tender offer or proxy contest, the assumption of control by a holder of a large block of our securities or the removal of incumbent management. Upon
S-3
TSHA
Taysha Gene Therapies Inc
5 Oct 21
Shelf registration
5:04pm
, the issuance of shares of preferred stock may render more difficult or tend to discourage a merger, tender offer or proxy contest, the assumption
- Prev
- 1
- Next